COVID-19 vaccination guidelines for patients with multiple sclerosis

Autor:	N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
Jazyk:	ruština
Rok vydání:	2021
Předmět:	multiple sclerosis disease modifying therapies covid-19 vaccination infections Neurology. Diseases of the nervous system RC346-429
Zdroj:	Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 2, Pp 157-161 (2021)
Druh dokumentu:	article
ISSN:	2074-2711 2310-1342
DOI:	10.14412/2074-2711-2021-2-157-161
Popis:	The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it is possible to use killed and inactivated vaccines. Preliminary recommendations are given for COVID-19 vaccination, taking into account the MS disease modifying therapies.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/160bfabe4e594d8393af8e0708c38546 Zobrazit plný text záznamu View record in DOAJ